Accelerating Phase: Supply Without Sacrificing Discipline

Speed in early clinical development is often treated as a tradeoff against rigor. The timeline case studies in this poster argue that rapid delivery is instead a product of disciplined execution across technical, operational, and quality functions. Bend Bioscience presents two Phase I examples. In one coated-tablet program, the objective was to produce, package, release, and ship clinical trial material within four months of contract signing; coated tablets were packaged and released for a Phase I study in 15 weeks. In a second spray-dried-dispersion-to-tablet program, the scope included formulation design, process and analytical method development, manufacturing, and release; fully released clinical supplies were delivered eight months after the first statement of work for SDD formulation design.

The poster attributes these timelines to a consistent operating model: transparent communication with sponsors, integrated project planning, joint ownership between technical leads and project management, cross-functional problem solving without functional silos, effective electronic data systems, and leadership experience. The deeper white paper opportunity is not simply to promote fast timelines, but to show how parallel workstreams and early alignment make speed reproducible.

When analytical development, formulation, process work, quality activities, manufacturing readiness, packaging, and release are visibly coordinated, the project team can identify dependencies earlier, manage decisions faster, and prevent avoidable handoff delays. The result is an execution model designed to absorb the uncertainty of early development while still protecting clinical-supply commitments.